Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Barclays updates FTSE stock targets, AstraZeneca and Admiral rise

EditorAmbhini Aishwarya
Published 27/11/2023, 10:56
Updated 27/11/2023, 10:56
© Reuters.

LONDON - Barclays (LON:BARC) has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and caution in its latest assessments. Beazley PLC (LON:BEZG) saw its price target trimmed but retained an 'Overweight' rating at £8.00. Aviva (LON:AV) PLC enjoyed a modest increase to £4.80, while Admiral Group (LON:ADML) PLC's target was ambitiously raised to £30.44.

In a contrasting move, Spirax-Sarco Engineering PLC (LON:SPX) faced a significant cut in its price target to £98.70 but maintained an 'Equal weight' status. AstraZeneca PLC (LON:AZN) also experienced a reduction in its target, now set at £125.00, yet the pharmaceutical giant continued to hold a 'Buy' rating.

This reshuffling of valuations follows a week of varied adjustments across the financial sector. On Friday, Burberry Group (OTC:BURBY) PLC's price target was dialed back by Deutsche Bank (ETR:DBKGn) to £19.50, reflecting a more conservative outlook.

In the FTSE mid-cap sector, Virgin Money (LON:VM) UK PLC navigated through downgraded forecasts from Citigroup and RBC, with their targets settling between £1.82 and £2.10, respectively. Direct Line Insurance Group PLC (LON:DLGD) and Just Group (LON:JUSTJ) PLC found favor in Barclays' eyes, as their targets were lifted, enhancing their market positions.

Even smaller-cap entities like Sabre (NASDAQ:SABR) Insurance Group PLC and Old Mutual Limited weren't left out of the adjustments, both receiving slight increases in their Barclays-set valuations.

The recalibrations come amid a broader context of market reevaluations by financial institutions. Peel Hunt (LON:PEEL) and Numis both upgraded Rightmove (OTC:RTMVY) PLC with a 'Buy' rating and a specific target of £6.75 by Numis. Conversely, Goldman Sachs (NYSE:GS) took a bearish turn on Entain (LON:ENT) PLC, slashing its price target from £14.50 to £8.20 and downgrading the stock from 'Buy' to 'Sell'.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In the energy sector, RBC Capital Markets has raised its sights on BP (NYSE:BP) PLC, setting an elevated target of £6.25 (GBP1 = USD1.2619) due to anticipated outperformance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.